RxDoctor Payments DataLook up a doctor →

Albert Coo, MD

Endocrinology, Diabetes & Metabolism · Alexandria, VANPI 1336160837

Payments from drug & device makers

$16,818in general payments, 2019–2025

Across 710 payments — averaging $23.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Corcept Therapeutics$5K
  • Lilly USA, LLC$2K
  • Novo Nordisk$1K
  • Sanofi-aventis U.S. LLC$1K
  • AbbVie$845
  • Xeris Pharmaceuticals, Inc.$843
  • plus $6K from 52 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Corcept Therapeutics65$4,640
Lilly USA, LLC94$1,807
Novo Nordisk71$1,333
Sanofi-aventis U.S. LLC68$1,086
AbbVie51$845
Xeris Pharmaceuticals, Inc.38$843
Amneal Pharmaceuticals LLC35$565
Bayer21$421
Merck24$384
AstraZeneca(2 entities)16$325
Mannkind Corporation14$295
Medtronic(2 entities)15$288
Boehringer Ingelheim13$249
Amarin Pharma, Inc.12$224
Recordati_rare_diseases_inc.11$219
Amgen(2 entities)9$216
Insulet Corporation10$179
Radius Health, Inc.7$171
Echosens North America, Inc.1$160
Viiv Healthcare Company10$154
BETA Bionics, Inc.7$154
IBSA Pharma Inc.9$147
Abbott7$145
Acella Pharmaceuticals, LLC7$143
Novartis6$119
Kyowa Kirin, Inc.5$109
Ascendis Pharma Endocrinology Inc4$99
Gilead4$94
Johnson & Johnson6$85
Dexcom, Inc.5$83
Antares Pharma, Inc.4$83
Madrigal Pharmaceuticals3$76
Takeda Pharmaceuticals U.S.A., Inc.4$75
Tandem Diabetes Care, Inc.4$71
Sequel Med Tech, LLC3$66
Tolmar, Inc.4$64
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC3$64
Pfizer4$64
Shire North American Group Inc4$64
Lifescan, Inc.3$61
EUSA Pharma (US) LLC2$56
Currax Pharmaceuticals LLC3$53
Embecta Corp.2$53
Zealand Pharma US, Inc.2$48
Acerus Pharmaceuticals Corporation3$47
Azurity Pharmaceuticals, Inc.2$44
Kowa Pharmaceuticals America, Inc.3$42
Clarus Therapeutics Inc.2$29
Theratechnologies Inc.1$24
Ultragenyx Pharmaceutical Inc.1$21
Almatica Pharma LLC1$21
Intuity Medical Inc1$18
Companion Medical, Inc.1$17
Valeritas, Inc.1$16
Regeneron Healthcare Solutions, Inc.1$15
Avion Pharmaceuticals1$15
Astellas Pharma US Inc1$14
Esperion Therapeutics, Inc.1$13

How this compares

$16,818 in reported general payments places this provider in the 85th percentile of 223 endocrinology, diabetes & metabolism providers in Virginia.

See all endocrinology, diabetes & metabolism providers in Virginia →

Medicare billing

Part B allowed, 2024
$122,250
Medicare patients
378
Services billed
1,772

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other endocrinology, diabetes & metabolism in Alexandria

See the full list for Virginia →

Where these figures come from

Is this you, or does something look wrong? →